Application

18746769 · Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate

Filed 2024-06-18 · Pending The official file ↗ · Art unit 1621 · Examiner Golam M Shameem Easy · CPC A61K 31/4985 · Acerta Pharma B.V. · Morgan, Lewis & Bockius LLP (Acerta)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

24.8 mo

to disposition n/a

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.